<http://webisa.webdatacommons.org/prov/355918515>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/382418971> .
<http://webisa.webdatacommons.org/382418971>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/prov/333745315>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/382418971> .
<http://webisa.webdatacommons.org/prov/463995268>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/382418971> .
<http://webisa.webdatacommons.org/382418971>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<freshpatents.com> .
<http://webisa.webdatacommons.org/382418971>	<http://www.w3.org/ns/prov#value>	"Agent: Paul D. Yasger Abbott Laboratories20080161293 - Antitumor agent: h20080161294 - Urea derivative, medicinal composition containing the same, and medicinal use of these: In the formula, R1 represents a hydrogen atom or a C1-6 alkyl group which may have a substituent, R2 is a hydrogen atom or a C1-6 alkyl group, R3 is a hydrogen atom, a C1-6 alkyl group or the like, R4, R5 and R6 are independe" .